School of Medicine
Showing 1-9 of 9 Results
-
Amna T. Adam
Postdoctoral Scholar, Neurosurgery
BioAmna earned her Bachelor of Science degree in chemistry and molecular biology from Montclair State University in 2015, where she also worked as a research assistant in the laboratory of Dr. David P. Rotella for 4-years. She pursued a PhD degree in Medicinal Chemistry at the University of Mississippi under the mentorship of Dr. David A. Colby, specializing in fluorine chemistry and organic synthesis. She conducted research on the interface of drug discovery, method development, and synthesis of fluorinated therapeutic for various diagnosis, such as cancer, drug addiction, and neurodegenerative disorders. She developed a method to efficiently synthesize Morpholine 3,3,3-trifluoropropanamide and commercialized this reagent with MilliporeSigma (911933) in 2020, which is currently valued at $326/500mg. Using this reagent she established a new method to access beta-fluoroalkenes, and important class of therapeutics that behave as peptide memetics. Also, she developed an efficient synthetic reaction to introduce methylene to L-γ-glutamine, which led to the successful synthesis of L-γ-methyleneglutamine that were tested for anticancer activity. Furthermore, she led the method development of fluortrifluoromethyl- and fluoropentafluorosulfanyl-containing methylene in the search of new highly fluorinated therapeutics. Currently, she is a postdoctoral scholar in the Shamloo Laboratory at Stanford Medicine. She works with Professor Shamloo on projects to develop novel therapeutics to treat drug addiction and neurodegenerative diseases.
-
Maheen Mausoof Adamson
Clinical Associate Professor (Affiliated) [Vapahcs], Neurosurgery
Staff, NeurosurgeryBioDr. Maheen Mausoof Adamson is a clinical associate professor of Neurosurgery (Affiliated) at Stanford School of Medicine and Clinical Research Director for Rehabilitation Services at VA Palo Alto. Adamson completed her undergraduate degrees in neurobiology and women studies at the University of California, Irvine. She completed her Ph.D. in neuroscience from the University of Southern California and a postdoctoral fellowship in Psychiatry and Behavioral Sciences at Stanford School of Medicine.
Dr. Adamson’s expertise and interests span employing translational neuroscience methodologies for diagnostic and neuromodulation treatments (such as repetitive Transcranial Magnetic Stimulation (rTMS)) for frequent health problems in patients with Traumatic Brain Injury (TBI), psychiatric problems, and Alzheimer's disease. She has employed advanced structural and functional imaging modalities and biomarker assessments in Veteran, active military and civilian populations with these health problems. She has been a leader in identifying gender differences in brain injury, particularly in the Veteran population. She currently serves as PI and Site-PI on numerous neuromodulation clinical trials and collaborates internationally for developing advanced diagnostic methods in neuroimaging, especially in underserved communities. In her position at VA Palo Alto, she is actively involved in translating research, such as non-invasive brain stimulation and other therapies, to clinical in-home use by patients using innovations such as virtual and augmented reality. Her latest efforts are assessment of stress in post-COVID population as well as association of Long COVID with long-term cognitive decline.
Dr. Adamson has authored numerous peer-reviewed publications on the cognitive and neural basis of Alzheimer’s disease and on a wide range of topics in TBI. She has received recognition in national and international settings. She is also intricately involved in mentoring research postdoctoral fellows and clinical residents in Physical Medicine & Rehabilitation, Psychiatry and Neurosurgery departments at Stanford School of Medicine. Her goal is to incorporate advanced treatment and diagnostics tailored to each patient's needs into standard-of-care to improve their daily function, reintegration into society and long-term rehabilitation. -
John R. Adler, MD
The Dorothy and Thye King Chan Professor in Neurosurgery, Emeritus
Current Research and Scholarly InterestsThe development and implementation of computerized, image-guided surgical tools to be used during minimally invasive brain operations. The clinical outcome of new technologies, and in particular the application of radiosurgery, for the treatment of brain tumors. The creation of new radiosurgical techniques for a wide array of brain and spine disorders.
-
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
